Method for treatment of acute renal failure

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31505

Patent

active

054865190

ABSTRACT:
A method is disclosed for treatment of acute renal failure which comprises administering to a warm-blooded mammal manifesting acute renal failure a small but effective amount of zaprinast sufficient to effect acceleration of recovery from said acute renal failure.

REFERENCES:
patent: 4496544 (1985-01-01), Needleman
Dundore, et al., Eur. J. Pharmacol. 249, 293-297 (1993).
McMahon, et al., J. Pharmacol. Exp. Therap. 251, 1000-1005 (1989).
Buchholz, et al., Fed. Am. Soc. Exp. Biol. J3, A1186 (1989).
Lugnier, et al., Am. J. Physiol. 262, H654-H660 (1992).
Burns, Chem. Absts. 117: 22314 (1992).
Needleman, et al., Hypertension 7, 469-482 (1985).
Cole, et al., J. Clin. Invest. 76(G), 2413-2415 (1985).
Needleman & Greenwald, New England J. Med. 314, 820-834 (1986).
Needleman, Fed. Proc. 45(7) 2096-2100 (1986).
Medline Abstract 92370201: Soales-da-Silva et al, "Effect of Alpha-Human Atrial Natriurtr Peptide on Synthesis of Dynamics in The Rat Kidney," Br J. Pharmacol. (1992 Apr.) 105(4) 869-74.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for treatment of acute renal failure does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treatment of acute renal failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treatment of acute renal failure will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1505158

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.